Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | BCL2 | P10415 | 1/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CTRC | Q99895 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10628200 | 0.81 | CYP1A2 (0.43) | CALM1HTR2ABCL2BCL2L1DAO | |
| SCHEMBL6210675 | 0.81 | HTR1A (0.44) | HTR2ANR1H2 | |
| SCHEMBL2870972 | 0.78 | CALM1 (0.46) | CALM1HTR2ABCL2BCL2L1CTRC | |
| SCHEMBL1252940 | 0.78 | TSHR (0.48) | CALM1HTR2ABCL2BCL2L1TSHR | |
| SCHEMBL11731628 | 0.77 | HTR2A (0.54) | CALM1HTR2ABCL2BCL2L1DAO | |
| SCHEMBL8070651 | 0.77 | CYP19A1 (0.42) | TSHR | |
| SCHEMBL16097299 | 0.76 | TSHR (0.56) | DAOL3MBTL1TSHR | |
| SCHEMBL6808133 | 0.76 | CYP11B1 (0.44) | CALM1BCL2BCL2L1CYP1A2CYP2D6 | |
| SCHEMBL9393660 | 0.76 | LOXL2 (0.42) | CALM1HTR2ADAOTSHRCYP1A2 | |
| SCHEMBL972711 | 0.75 | CALM1 (0.69) | CALM1HTR2ABCL2BCL2L1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11091597-B2 | Packaging material and methods of using the same | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-08-17 | — | — | US | claimed |
| US-20210061965-A1 | PACKAGING MATERIAL AND METHODS OF USING THE SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2021-03-04 | — | — | US | claimed |
| CN-109691450-A | The purposes of N- benzyl benzamide compound and combinations thereof, mix preparation | 利民化工股份有限公司 | 2019-04-30 | — | — | CN | claimed |
| US-20180340049-A1 | PACKAGING MATERIAL AND METHODS OF USING THE SAME | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2018-11-29 | — | — | US | claimed |
| WO-2017203303-A1 | IMIDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH CELL CYCLE DYSREGULATION | UNIVERSITY OF PATRAS (GR) | 2017-11-30 | — | — | WO | claimed |
| WO-2016128885-A1 | A PROCESS FOR PREPARATION OF COBICISTAT | LAURUS LABS PRIVATE LIMITED (IN) | 2016-08-18 | — | — | WO | claimed |
| US-20080234300-A1 | Pyrimido[5,4-c] Quinoline-2, 4-Diamine Derivatives and Methods of Use Thereof | WYETH (US) | 2008-09-25 | — | — | US | claimed |
| WO-2008109599-A1 | PYRIMIDO [5,4-C] QUINOLINE-2, 4-DIAMINE DERIVATIVES AND METHODS OF USE THEREOF | WYETH (US) | 2008-09-12 | — | — | WO | claimed |
| EP-1466884-A1 | Process for the preparation of resveratrol and its uses | Sochinaz SA (CH) | 2004-10-13 | — | — | EP | claimed |
| US-6764509-B2 | Prosthetic heart valve with surface modification | CARBOMEDICS INC. | 2004-07-20 | — | — | US | claimed |
| EP-1307418-A2 | PROCESS FOR THE PREPARATION OF CHIRAL 1,4-DIARYL-2-FLUORO-2-BUTENES | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-07 | — | — | EP | claimed |
| WO-2002012155-A2 | PROCESS FOR THE PREPARATION OF CHIRAL 1,4-DIARYL-2-FLUORO-2-BUTENES | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-14 | — | — | WO | claimed |
| US-20010025196-A1 | Prosthetic heart valve with surface modification | CORCYM S.R.L. (IT) | 2001-09-27 | — | — | US | claimed |
| EP-0192210-B1 | CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-10-21 | — | — | EP | claimed |
| EP-0408973-A1 | Antiherpes pentapeptides | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1991-01-23 | — | — | EP | claimed |
| EP-0254322-A1 | Benzimidazole derivatives | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1988-01-27 | — | — | EP | claimed |
| EP-0106114-B1 | FUNCTIONAL DERIVATIVES OF ACETIC ACID CONTAINING PHOSPHORUS, PROCESS FOR PREPARING THEM AND HERBICIDAL AND GROWTH REGULATING COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-11-12 | — | — | EP | claimed |
| JP-10139604-A | — | — | None | — | — | JP | disclosed |
| EP-0254322-A1 | Benzimidazole derivatives | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1988-01-27 | — | — | EP | disclosed |
| US-3936394-A | Polymer adsorbents and method for manufacture thereof | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061965-A1 | PACKAGING MATERIAL AND METHODS OF USING THE SAME | PARG, PARN, PCBP1 | CALM1 4465/4885HTR2A 1113/4885BCL2 1255/4885 |
| US-20180340049-A1 | PACKAGING MATERIAL AND METHODS OF USING THE SAME | PARG, PARN, PCBP1 | CALM1 4465/4885HTR2A 1113/4885BCL2 1255/4885 |
| US-11091597-B2 | Packaging material and methods of using the same | PARG, PARN, PCBP1 | CALM1 4465/4885HTR2A 1113/4885BCL2 1255/4885 |
| US-20080234300-A1 | Pyrimido[5,4-c] Quinoline-2, 4-Diamine Derivatives and Methods of Use Thereof | DCK, PDK4, PDK2 | CALM1 1696/4885HTR2A 1476/4885BCL2 1484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.